BioSpace News Archive

Business

ViewRay Announces Preliminary Fourth Quarter and Fiscal Year 2017 Results

ViewRay today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2017.

January 8, 2018
·
3 min read
Drug Development

Infinity Provides Update on IPI-549 Phase I/Ib Study, 2018 Goals and Financial Guidance

Infinity Pharma today announced the achievement of four development milestones for IPI-549 thereby reducing pro-tumor macrophage function and increasing anti-tumor macrophage function.

January 8, 2018
·
10 min read
Business

Air Techniques Welcomes Casey Baldwin as Director of Sales

Mr. Baldwin has over 10 years of experience in the dental industry. Most recently, he held the position of Director of Sales, West at Dentsply Sirona Implants, where he developed and implemented strategic initiatives and managed directly a team of 6 Regional Managers, and indirectly 48 District Managers.

January 8, 2018
·
1 min read
Business

Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement

Alliance to focus on regulatory approval, commercialization and marketing of novel apabetalone therapy in Israel.

January 8, 2018
·
5 min read
Business

Renowned Scientists Join Rady Children’s Institute for Genomic Medicine Scientific Advisory Board

The RCIGM is pleased to announce that six influential life science researchers have been recruited to serve on the Institute’s inaugural Scientific Advisory Board.

January 8, 2018
·
5 min read
Sensus Healthcare Brings Superficial Radiation Therapy (SRT) to China for Keloid Prevention and Treatment

Sensus Healthcare today announced that the Company has shipped three of its SRT-100 units to Chindex Medical Limited.

January 8, 2018
·
2 min read
Biotech Beach

Heron Therapeutics Highlights Progress in CINV and Pain Management Franchises

Heron today highlighted progress in the Company’s pain management and CINV franchises.

January 8, 2018
·
7 min read
Pharm Country

Pfizer Inc. Announces Expiration and Results of its Tender Offer for its 5.750 per cent. Notes due 2021 and Related Solicitation of Consents

Pfizer Inc. today announced the expiration and results of its previously announced (i) offer to purchase for cash any and all of its outstanding €2,000,000,000 5.750 per cent.

January 8, 2018
·
9 min read
BioCapital

Sabin to Tackle Pandemic Flu

Sabin Vaccine Institute, is pleased to announce a new three-year $6.6M grant to help speed the development of next generation influenza vaccines and support related immunization issues.

January 8, 2018
·
3 min read
Policy

Clearbridge BioMedics’ ClearCell FX1 System Achieves U.S. FDA listing

Clearbridge BioMedics today announced that it has successfully registered its target cell enrichment device, the ClearCell FX1 system, with the FDA as a Class I Medical Device, for in vitro diagnostic use.

January 8, 2018
·
2 min read